Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
基本信息
- 批准号:10308527
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2022-09-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAgeBlood PressureBlood VesselsBreast Cancer DetectionCaringCharacteristicsChronicClinicClinicalClinical DataColorectalColorectal CancerDataDecision MakingDementiaDevelopmentDiagnosisDiagnostic testsDiscriminationDisseminated Malignant NeoplasmDistressElderlyElectronic Health RecordFoundationsFrail ElderlyFutureGoalsGoldGuidelinesHarm ReductionHealthcare SystemsHypoglycemiaIndividualInterventionLaboratoriesLeadLearningLife ExpectancyLinkMalignant NeoplasmsMeasurementMeasuresMedical centerMedicareModelingNeeds AssessmentPSA screeningPatientsPerformancePharmacy facilityPredictive ValuePreventionPrimary Health CareProviderRecordsResearchRiskRisk FactorsScreening for cancerSensitivity and SpecificityStatistical sensitivitySymptomsSystemTestingTimeValidationVeteransWorkbaseclinical decision-makingcohortcolorectal cancer screeningcomorbiditydemographicsdiabeticelectronic datafallsfunctional statusglycemic controlimprovedindexingindividualized preventioninstrumental activity of daily livingmortalitymortality riskpoint of carepreventive interventionscreeningstatisticstool
项目摘要
Ignoring life expectancy can lead to poor clinical decisions. Healthy older adults who could benefit from
screening have low screening rates. Older adults with dementia or metastatic cancer are screened for slow-
growing cancers that are unlikely to cause symptoms but may lead to distress from false-positive results,
invasive work-ups and treatments. Life expectancy calculators offer the possibility of moving beyond arbitrary
age-based cutoffs to more rational life expectancy based decision-making, incorporating age as well as other
factors known to predict mortality such as comorbidities, demographics, laboratory results and pharmacy data.
The objectives of the study are to (a) develop and validate a 10-year life expectancy calculator using
2005 VA electronic data (demographics, comorbidities, laboratory results and pharmacy records); (b) develop
and validate an Augmented life expectancy calculator that adds 2009 functional assessments (Activities of
Daily Living or ADL and Instrumental Activities of Daily Living or IADL assessments) to the other risk factors
and determine whether the addition of ADL and IADL data lead to improved discrimination; ); (c) develop and
validate a VA-Medicare life expectancy calculator that adds 2009 Medicare data to the other risk factors and
determine whether the addition of Medicare data lead to improved discrimination; (d) apply the life expectancy
calculator to a national VA cohort to determine the proportion of colorectal cancer (CRC) screening that occurs
in veterans with limited life expectancy (<25% likelihood of life expectancy of 10+ years) and extended life
expectancy (>75% likelihood of life expectancy of 10+ years) in both veterans within the recommended age
(50-75) for CRC screening as well as veterans at more advanced age (76-85) when screening is not routinely
recommended.
By developing and validating a VA electronic data driven life expectancy calculator, this project will
determine the rates of potentially inappropriate CRC overscreening in age-appropriate veterans (age 50-75)
with a limited life expectancy (<25% likelihood of life expectancy 10+ years). Conversely, this project will also
identify potentially inappropriate CRC underscreening in veterans beyond the recommend age for screening
(age 76-85) with an extended life expectancy (>75% likelihood of life expectancy of 10+ years). This work will
provide the critical foundation for an intervention to improve the targeting of CRC screening will estimate an
individual veterans' life expectancy to 1) suppress CRC screening clinical reminders for patients with limited life
expectancy (age 50-75) or 2) trigger CRC screening clinical reminders for patients with extended life
expectancy (age 76-85). Further, accurate life expectancy estimates could also be utilized to individualize
other prevention decisions that have a long time to benefit, such as breast cancer screening and intensive
glycemic control. Thus, this work would be another way that the VA would become a Learning Healthcare
System that uses clinical data to individualize veterans' prevention decisions and inform system-wide decisions
regarding prevention clinical alerts.
忽视预期寿命会导致糟糕的临床决策。健康的老年人可以受益于
筛查率低。患有痴呆症或转移性癌症的老年人接受慢-
生长中的癌症不太可能引起症状,但可能导致假阳性结果的困扰,
侵入性检查和治疗。预期寿命计算器提供了超越武断的可能性,
以年龄为基础的截止值,以更合理的预期寿命为基础的决策,包括年龄以及其他
已知可预测死亡率的因素,如合并症、人口统计学、实验室结果和药房数据。
这项研究的目标是:(a)开发和验证一个10年预期寿命计算器,
2005年VA电子数据(人口统计学、合并症、实验室结果和药房记录);(B)制定
并验证一个增加了2009年功能评估的预期寿命计算器(
日常生活或ADL和工具性日常生活活动或IADL评估)与其他风险因素
并确定ADL和IADL数据的添加是否导致改善的辨别力;);(c)开发和
验证VA医疗保险预期寿命计算器,该计算器将2009年医疗保险数据添加到其他风险因素中,
确定医疗保险数据的增加是否会导致歧视的改善;(d)适用预期寿命
计算器到国家VA队列,以确定发生结肠直肠癌(CRC)筛查的比例
在预期寿命有限的退伍军人(<25%的预期寿命可能性为10年以上)和延长寿命的退伍军人中,
在推荐年龄内,两名退伍军人的预期寿命(10年以上预期寿命的可能性>75%)
(50-75)以及年龄较大的退伍军人(76-85),当筛查不是常规时,
推荐
通过开发和验证VA电子数据驱动的预期寿命计算器,该项目将
确定年龄合适的退伍军人(50-75岁)中潜在不适当的CRC过度筛查率
预期寿命有限(预期寿命10年以上的可能性<25%)。此外,该项目还将
在超过推荐筛查年龄的退伍军人中识别潜在不适当的CRC筛查不足
(age 76-85岁),预期寿命延长(10年以上预期寿命的可能性>75%)。这项工作将
为干预措施提供关键基础,以提高CRC筛查的针对性,
个体退伍军人的预期寿命1)抑制CRC筛查临床提示患者寿命有限
预期(年龄50-75)或2)触发CRC筛查临床提醒延长寿命的患者
预期寿命(76-85岁)。此外,还可以利用准确的预期寿命估计来个性化地
其他预防决策,有很长的时间受益,如乳腺癌筛查和密集
血糖控制因此,这项工作将是另一种方式,退伍军人管理局将成为一个学习医疗保健
使用临床数据的系统,以个性化退伍军人的预防决策,并告知全系统的决策
关于预防临床警报。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Making Function Part of the Conversation: Clinician Perspectives on Measuring Functional Status in Primary Care.
让功能成为对话的一部分:临床医生对初级保健功能状态测量的看法。
- DOI:10.1111/jgs.15677
- 发表时间:2019
- 期刊:
- 影响因子:6.3
- 作者:Nicosia,FrancescaM;Spar,MalenaJ;Steinman,MichaelA;Lee,SeiJ;Brown,RebeccaT
- 通讯作者:Brown,RebeccaT
Exploring the Dynamics of Week-to-Week Blood Pressure in Nursing Home Residents Before Death.
探索疗养院居民生前每周血压的动态。
- DOI:10.1093/ajh/hpab142
- 发表时间:2022
- 期刊:
- 影响因子:3.2
- 作者:Graham,LauraA;Lee,SeiJ;Steinman,MichaelA;Peralta,CarmenA;Rubinsky,AnnaD;Jing,Bocheng;Fung,KathyZ;Odden,MichelleC
- 通讯作者:Odden,MichelleC
Sliding scale insulin use in a national cohort study of nursing home residents with type 2 diabetes.
- DOI:10.1111/jgs.17771
- 发表时间:2022-07
- 期刊:
- 影响因子:6.3
- 作者:Lam, Kenneth;Gan, Siqi;Nguyen, Brian;Jing, Bocheng;Lee, Sei J.
- 通讯作者:Lee, Sei J.
Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes.
- DOI:10.1111/jgs.17735
- 发表时间:2022-07
- 期刊:
- 影响因子:6.3
- 作者:Lederle, Lauren, I;Steinman, Michael A.;Jing, Bocheng;Nguyen, Brian;Lee, Sei J.
- 通讯作者:Lee, Sei J.
Frailty and mortality: 'Same-same but Different'.
虚弱和死亡:“相同但不同”。
- DOI:10.1136/bmjqs-2018-008821
- 发表时间:2019
- 期刊:
- 影响因子:5.4
- 作者:Lee,SeiJ
- 通讯作者:Lee,SeiJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sei Lee其他文献
Sei Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sei Lee', 18)}}的其他基金
Prognostic Indices for Hospitalized Older Adults with and without Alzheimer’s Disease and Related Dementias
患有或不患有阿尔茨海默病和相关痴呆症的住院老年人的预后指数
- 批准号:
10740664 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
- 批准号:
9953776 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
- 批准号:
10328473 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
- 批准号:
10616657 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Prognostic calculators for patients with Alzheimers disease and related dementias
阿尔茨海默病和相关痴呆症患者的预后计算器
- 批准号:
9912083 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Prognostic calculators for patients with Alzheimers disease and related dementias
阿尔茨海默病和相关痴呆症患者的预后计算器
- 批准号:
9762780 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
- 批准号:
9757611 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
- 批准号:
10186503 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Developing prognostic models for life expectancy and geriatric outcomes
开发预期寿命和老年结局的预后模型
- 批准号:
9067881 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Developing prognostic models for life expectancy and geriatric outcomes
开发预期寿命和老年结局的预后模型
- 批准号:
9390251 - 财政年份:2015
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




